Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Alternative lengthening of telomeres is associated with chromosomal instability in osteosarcomas

Abstract

Telomere maintenance is regarded as a key mechanism in overcoming cellular senescence in tumor cells and in most cases is achieved by the activation of telomerase. However there is at least one alternative mechanism of telomere lengthening (ALT) which is characterized by heterogeneous and elongated telomeres in the absence of telomerase activity (TA). We evaluated the prevalence of TA, gene expression of telomerase subunits and ALT in relation to telomere morphology and function in matrix producing bone tumors and in osteosarcoma cell lines and present evidence of a direct association of ALT with telomere dysfunction and chromosomal instability. Telomere fluorescence in situ hybridization (T-FISH) in ALT cells revealed elongated and shortened telomeres, partly in unusual configurations and loci, dicentric marker chromosomes and signal-free chromosome ends. Free ends give rise to end-to-end associations and may induce breakage-fusion-bridge cycles resulting in an increased number of complex chromosomal rearrangements, as detected by multiplex-FISH (M-FISH). We propose that ALT cannot be seen as an equivalent to telomerase activity in telomere maintenance. Its association with telomere dysfunction and chromosomal instability may have major implications for tumor progression.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

References

  • Aue G, Muralidhar B, Schwartz HS, Butler MG . 1998 Ann. Surg. Oncol. 5: 627–634

  • Autexier C, Greider CW . 1996 Trends Biochem. Sci. 21: 387–391

  • Avilion AA, Piatyszek MA, Gupta J, Shay JW, Bacchetti S, Greider CW . 1996 Cancer Res. 56: 645–650

  • Biessmann H, Mason JM . 1997 Chromosoma 106: 63–69

  • Bouffler SD, Morgan WF, Pandita TK, Slijepcevic P . 1996 Mutat. Res. 366: 129–135

  • Brinkschmidt C, Poremba C, Christiansen H, Simon R, Schafer KL, Terpe HJ, Lampert F, Boecker W, Dockhorn-Dworniczak B . 1998 Br. J. Cancer 77: 2223–2229

  • Broccoli D, Young JW, de LT . 1995 Proc. Natl. Acad. Sci. USA 92: 9082–9086

  • Bryan TM, Englezou A, Dalla-Pozza L, Dunham MA, Reddel RR . 1997 Nat. Med. 3: 1271–1274

  • Bryan TM, Englezou A, Gupta J, Bacchetti S, Reddel RR . 1995 EMBO J. 14: 4240–4248

  • Bryce LA, Morrison N, Hoare SF, Muir S, Keith WN . 2000 Neoplasia 2: 197–201

  • Chen PL, Chen YM, Bookstein R, Lee WH . 1990 Science 250: 1576–1580

  • Counter CM, Avilion AA, LeFeuvre CE, Stewart NG, Greider CW, Harley CB, Bacchetti S . 1992 EMBO J. 11: 1921–1929

  • Counter CM, Gupta J, Harley CB, Leber B, Bacchetti S . 1995 Blood 85: 2315–2320

  • Counter CM, Hahn WC, Wei W, Caddle SD, Beijersbergen RL, Lansdorp PM, Sedivy JM, Weinberg RA . 1998 Proc. Natl. Acad. Sci. USA 95: 14723–14728

  • Ducray C, Pommier JP, Martins L, Boussin FD, Sabatier L . 1999 Oncogene 18: 4211–4223

  • Eils R, Uhrig S, Saracoglu K, Satzler K, Bolzer A, Petersen I, Chassery J, Ganser M, Speicher MR . 1998 Cytogenet. Cell. Genet. 82: 160–171

  • Greider CW, Blackburn EH . 1987 Cell 51: 887–898

  • Harle BC, Boukamp P . 1996 Proc. Natl. Acad. Sci. USA 93: 6476–6481

  • Hiyama E, Hiyama K, Tatsumoto N, Kodama T, Shay JW, Yokoyama T . 1996 Int. J. Oncol. 9: 453–458

  • Hiyama K, Hirai Y, Kyoizumi S, Akiyama M, Hiyama E, Piatyszek MA, Shay JW, Ishioka S, Yamakido M . 1995 J. Immunol. 155: 3711–3715

  • Ito H, Kyo S, Kanaya T, Takakura M, Inoue M, Namiki M . 1998 Clin. Cancer Res. 4: 1603–1608

  • Kass-Eisler A, Greider CW . 2000 Trends Biochem. Sci. 25: 200–204

  • Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PL, Coviello GM, Wright WE, Weinrich SL, Shay JW . 1994 Science 266: 2011–2015

  • Landers JE, Cassel SL, George DL . 1997 Cancer Res. 57: 3562–3568

  • Lansdorp PM, Verwoerd NP, van de Rijke FM, Dragowska V, Little MT, Dirks RW, Raap AK, Tanke HJ . 1996 Hum. Mol. Genet. 5: 685–691

  • McClintock B . 1941 Genetics 26: 234–282

  • Melek M, Shippen DE . 1996 Bioessays 18: 301–308

  • Meyerson M, Counter CM, Eaton EN, Ellisen LW, Steiner P, Caddle SD, Ziaugra L, Beijersbergen RL, Davidoff MJ, Liu Q, Bacchetti S, Haber DA, Weinberg RA . 1997 Cell 90: 785–795

  • Mitchell JR, Wood E, Collins K . 1999 Nature 402: 551–555

  • Olovnikov AM . 1971 Dokl Akad Nauk. 201: 1496–1499

  • Perrem K, Bryan TM, Englezou A, Hackl T, Moy EL, Reddel RR . 1999 Oncogene 18: 3383–3390

  • Poremba C, Bocker W, Willenbring H, Schafer KL, Otterbach F, Burger H, Diallo R, Dockhorn DB . 1998 Int. J. Oncol. 12: 641–648

  • Poremba C, Scheel C, Hero B, Christiansen H, Schaefer KL, Nakayama J, Berthold F, Juergens H, Boecker W, Dockhorn-Dworniczak B . 2000 J. Clin. Oncol. 18: 2582–2592

  • Poremba C, Shroyer KR, Frost M, Diallo R, Fogt F, Schäfer K, Bürger H, Shroyer AL, Dockhorn-Dworniczak B, Boecker W . 1999 J. Clin. Oncol. 17: 2020–2026

  • Radig K, Schneider-Stock R, Haeckel C, Neumann W, Roessner A . 1998 Hum. Pathol. 29: 1310–1316

  • Ramakrishnan S, Eppenberger U, Mueller H, Shinkai Y, Narayanan R . 1998 Cancer Res. 58: 622–625

  • Romano JW, Ehrhart JC, Duthu A, Kim CM, Appella E, May P . 1989 Oncogene 4: 1483–1488

  • Shay JW . 1999 J. Natl. Cancer Inst. 91: 4–6

  • Shay JW, Bacchetti S . 1997 Eur. J. Cancer 33: 787–791

  • Speicher MR, Gwyn BS, Ward DC . 1996 Nat. Genet. 12: 368–375

  • Sumida T, Hamakawa H, Sogawa K, Sugita A, Tanioka H, Ueda N . 1999 Int. J. Cancer 80: 1–4

  • Takakura M, Kyo S, Kanaya T, Tanaka M, Inoue M . 1998 Cancer Res. 58: 1558–1561

  • Takubo K, Nakamura K, Izumiyama N, Mafune K, Tanaka Y, Miyashita M, Sasajima K, Kato M, Oshimura M . 1997 J. Surg. Oncol. 66: 88–92

  • Tanaka H, Shimizu M, Horikawa I, Kugoh H, Yokota J, Barrett JC, Oshimura M . 1998 Genes Chromosomes Cancer 23: 123–133

  • Watson JD . 1972 Nat. New Biol. 239: 197–201

  • Wright WE, Brasiskyte D, Piatyszek MA, Shay JW . 1996 EMBO J. 15: 1734–1741

  • Wright WE, Pereira SO, Shay JW, et al. 1989 Mol. Cell. Biol. 9: 3088–3092

  • Wynford-Thomas D . 1999 J. Pathol. 187: 100–111

  • Zhu X, Kumar R, Mandal M, Sharma N, Sharma HW, Dhingra U, Sokoloski JA, Hsiao R, Narayanan R . 1996 Proc. Natl. Acad. Sci. USA 93: 6091–6095

Download references

Acknowledgements

We would like to thank Dagmar Haves, Frauke Schmidt, Petra Meier and Lydia Grote for excellent technical assistance. We would also like to thank Andreas Scheel for useful advice. Supported in part by the German Research Foundation “Deutsche Forschungsgemeinschaft DFG” (grant nos. Po. 529/4-1 and Po. 529/5-1) and the IZKF Muenster (grant nos. G2 and H2).

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Scheel, C., Schaefer, KL., Jauch, A. et al. Alternative lengthening of telomeres is associated with chromosomal instability in osteosarcomas. Oncogene 20, 3835–3844 (2001). https://doi.org/10.1038/sj.onc.1204493

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1204493

Keywords

This article is cited by

Search

Quick links